These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 28693230

  • 1. Apogossypolone induces apoptosis and autophagy in nasopharyngeal carcinoma cells in an in vitro and in vivo study.
    Zheng R, Chen K, Zhang Y, Huang J, Shi F, Wu G, Wang S.
    Oncol Lett; 2017 Jul; 14(1):751-757. PubMed ID: 28693230
    [Abstract] [Full Text] [Related]

  • 2. Apogossypolone, a small-molecule inhibitor of Bcl-2, induces radiosensitization of nasopharyngeal carcinoma cells by stimulating autophagy.
    He JH, Liao XL, Wang W, Li DD, Chen WD, Deng R, Yang D, Han ZP, Jiang JW, Zhu XF.
    Int J Oncol; 2014 Sep; 45(3):1099-108. PubMed ID: 24919770
    [Abstract] [Full Text] [Related]

  • 3. Apogossypolone induces autophagy and apoptosis in breast cancer MCF-7 cells in vitro and in vivo.
    Niu X, Li S, Wei F, Huang J, Wu G, Xu L, Xu D, Wang S.
    Breast Cancer; 2014 Mar; 21(2):223-30. PubMed ID: 22711315
    [Abstract] [Full Text] [Related]

  • 4. ApoG2, a novel inhibitor of antiapoptotic Bcl-2 family proteins, induces apoptosis and suppresses tumor growth in nasopharyngeal carcinoma xenografts.
    Hu ZY, Zhu XF, Zhong ZD, Sun J, Wang J, Yang D, Zeng YX.
    Int J Cancer; 2008 Nov 15; 123(10):2418-29. PubMed ID: 18712728
    [Abstract] [Full Text] [Related]

  • 5. Apogossypolone inhibits the proliferation of LNCaP cells in vitro and in vivo.
    Zhang X, Hu X, Mu S, Zhan Y, An Q, Liu Z, Huang X.
    Mol Med Rep; 2014 Sep 15; 10(3):1184-94. PubMed ID: 25060748
    [Abstract] [Full Text] [Related]

  • 6. Synergistic antitumoral activity and induction of apoptosis by novel pan Bcl-2 proteins inhibitor apogossypolone with adriamycin in human hepatocellular carcinoma.
    Mi JX, Wang GF, Wang HB, Sun XQ, Ni XY, Zhang XW, Tang JM, Yang DJ.
    Acta Pharmacol Sin; 2008 Dec 15; 29(12):1467-77. PubMed ID: 19026166
    [Abstract] [Full Text] [Related]

  • 7. Apogossypolone targets mitochondria and light enhances its anticancer activity by stimulating generation of singlet oxygen and reactive oxygen species.
    Hu ZY, Wang J, Cheng G, Zhu XF, Huang P, Yang D, Zeng YX.
    Chin J Cancer; 2011 Jan 15; 30(1):41-53. PubMed ID: 21192843
    [Abstract] [Full Text] [Related]

  • 8. ApoG2 induces cell cycle arrest of nasopharyngeal carcinoma cells by suppressing the c-Myc signaling pathway.
    Hu ZY, Sun J, Zhu XF, Yang D, Zeng YX.
    J Transl Med; 2009 Aug 23; 7():74. PubMed ID: 19698176
    [Abstract] [Full Text] [Related]

  • 9. Apogossypolone, a nonpeptidic small molecule inhibitor targeting Bcl-2 family proteins, effectively inhibits growth of diffuse large cell lymphoma cells in vitro and in vivo.
    Sun Y, Wu J, Aboukameel A, Banerjee S, Arnold AA, Chen J, Nikolovska-Coleska Z, Lin Y, Ling X, Yang D, Wang S, Al-Katib A, Mohammad RM.
    Cancer Biol Ther; 2008 Sep 23; 7(9):1418-26. PubMed ID: 18769131
    [Abstract] [Full Text] [Related]

  • 10. ApoG2 as the most potent gossypol derivatives inhibits cell growth and induces apoptosis on gastric cancer cells.
    Xin J, Zhan YH, Xia LM, Zhu HW, Nie YZ, Liang JM, Tian J.
    Biomed Pharmacother; 2013 Feb 23; 67(1):88-95. PubMed ID: 23201009
    [Abstract] [Full Text] [Related]

  • 11. ApoG2 inhibits the antiapoptotic protein, Mcl‑1, and induces mitochondria‑dependent apoptosis in human colorectal cancer cells.
    Li T, Yuan G, Zhang L, Ye L, Li S, Fan Y, Sun J.
    Mol Med Rep; 2015 Nov 23; 12(5):6976-84. PubMed ID: 26352605
    [Abstract] [Full Text] [Related]

  • 12. [Effect of apogossypolone on induction apoptosis in multiple myeloma cells and its mechanisms].
    Lin J, Wu YJ, Yang DJ, Zhao YQ.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb 23; 17(1):92-8. PubMed ID: 19236755
    [Abstract] [Full Text] [Related]

  • 13. ApoG2 inhibits antiapoptotic Bcl-2 family proteins and induces mitochondria-dependent apoptosis in human lymphoma U937 cells.
    Sun J, Li ZM, Hu ZY, Lin XB, Zhou NN, Xian LJ, Yang DJ, Jiang WQ.
    Anticancer Drugs; 2008 Nov 23; 19(10):967-74. PubMed ID: 18827561
    [Abstract] [Full Text] [Related]

  • 14. Apogossypolone (ApoG2) induces ROS-dependent apoptosis and reduces invasiveness of PC12 cells in vitro and in vivo.
    Lin D, Li X, Xu L, Lian J, Xu Y, Meng L, Xie X, Wang X, He H, Xu D, Wang C, Zhu Y.
    Am J Transl Res; 2017 Nov 23; 9(9):3990-4002. PubMed ID: 28979675
    [Abstract] [Full Text] [Related]

  • 15. ApoG2 induces ER stress-dependent apoptosis in gastric cancer cells in vitro and its real-time evaluation by bioluminescence imaging in vivo.
    Xin J, Zhan Y, Liu M, Hu H, Xia L, Nie Y, Wu K, Liang J, Tian J.
    Cancer Lett; 2013 Aug 19; 336(2):260-9. PubMed ID: 23523614
    [Abstract] [Full Text] [Related]

  • 16. Effects of an oral allosteric AKT inhibitor (MK-2206) on human nasopharyngeal cancer in vitro and in vivo.
    Zhao YY, Tian Y, Zhang J, Xu F, Yang YP, Huang Y, Zhao HY, Zhang JW, Xue C, Lam MH, Yan L, Hu ZH, Dinglin XX, Zhang L.
    Drug Des Devel Ther; 2014 Aug 19; 8():1827-37. PubMed ID: 25336925
    [Abstract] [Full Text] [Related]

  • 17. Apogossypolone inhibits cell growth by inducing cell cycle arrest in U937 cells.
    Sun J, Li ZM, Hu ZY, Zeng ZL, Yang DJ, Jiang WQ.
    Oncol Rep; 2009 Jul 19; 22(1):193-8. PubMed ID: 19513523
    [Abstract] [Full Text] [Related]

  • 18. Growth inhibition and apoptosis induction of human umbilical vein endothelial cells by apogossypolone.
    Zhan YH, Huang XF, Hu XB, An QX, Liu ZX, Zhang XQ.
    Asian Pac J Cancer Prev; 2013 Jul 19; 14(3):1791-5. PubMed ID: 23679275
    [Abstract] [Full Text] [Related]

  • 19. Apogossypolone induces reactive oxygen species accumulation and controls cell cycle progression in Raji Burkkit's lymphoma cells.
    Hu ZY, Xu F, Sun R, Chen YF, Zhang DS, Fan YH, Sun J.
    Mol Med Rep; 2015 Jul 19; 12(1):337-44. PubMed ID: 25738577
    [Abstract] [Full Text] [Related]

  • 20. Apogossypolone Inhibits Cell Proliferation and Epithelial-Mesenchymal Transition in Cervical Cancer via Activating DKK3.
    Li Y, Qu J, Liu L, Sun Y, Zhang J, Han S, Zhang Y.
    Front Oncol; 2022 Jul 19; 12():948023. PubMed ID: 35924156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.